Plus: Lockheed Martin shares climb after Pentagon urges more missile production. And MoonLake Immunotherapeutics posts disappointing trial results for skin-disorder drug. Katherine Sullivan hosts. Sign up for the WSJ's free What's News newsletter. An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.